News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
AI tools to improve diagnosis and therapy in neuro-oncology
Pearl Freier and Javier E Villanueva-Meyer
Nov 13, 2024, 09:39

AI tools to improve diagnosis and therapy in neuro-oncology

Pearl Freier, Founder of Cambridge BioPartners, shared a recent article by Javier E Villanueva-Meyer on X:

“AI tools to improve diagnosis and therapy in neuro-oncology are increasing and The Lancet Oncology review provides an assessment of the field with focus on Artificial Intelligence for Response Assessment in Neuro Oncology. 

AI models of key genomic markers and predictive AI models of response before and after therapy.”

Title: Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements

Authors: Javier E Villanueva-Meyer, Spyridon Bakas, Janine M Lupo, Evan Calabrese, Christos Davatzikos, Wenya Linda Bi, Marwa Ismail, Hamed Akbari, Philipp Lohmann, Thomas C Booth, Benedikt Wiestler, Hugo J W L Aerts, Ghulam Rasool, Joerg C Tonn, Martha Nowosielski, Rajan Jain, Rivka R Colen, Sarthak Pati, Ujjwal Baid, Philipp Vollmuth, David Macdonald, Michael A Vogelbaum, Susan M Chang, Raymond Y Huang and Norbert Galldiks

Pearl Freier-AI tools-neuro-oncology

For more updates, follow OncoDaily.

AI tools cancer Evan Calabrese Janine M Lupo Javier E Villanueva-Meyer Michael A. Vogelbaum Neuro-Oncology Norbert Galldiks OncoDaily Oncology Pearl Freier Raymond Y Huang Spyridon Bakas Susan M. Chang The Lancet Oncology
Special Coverage
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing
Blog
Nov 13, 2024, 08:49
Yüksel Ürün: Promising findings on SGLT2 as a biomarker for papillary RCC by Erman Akkus
Blog
Nov 13, 2024, 08:46
Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer
Blog
Nov 13, 2024, 08:39
Eva Blondeaux on safety of pregnancy in BRCA carriers